Cindy Liu is a Principal at Qiming Venture Partners. She focuses on biotech investments in the healthcare sector, particularly in disease areas such as oncology, metabolic diseases, immunology and inflammatory diseases, cardiovascular diseases, CNS, and respiratory diseases among others.
Cindy joined Qiming in 2018. Prior to that, she worked at EY-Parthenon as a Manager in Corporate Strategy & Transaction Advisory. Before that, she was a consultant at IQVIA, working on projects related to product market assessment, due diligence, new product launch strategy, and growth strategy.
Cindy holds a Master's degree and M.D., and B.S. in Preventive Medicine from Fudan University.
